SUSPENDED

Cleansing Device for the Treatment of Scalp and Hair Conditions

Talk to us

Conditions

DandruffSeborrheic DermatitisHair Loss

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this study is to evaluate an improvement of scalp health after the use of an investigational off-label WaterPik and brush device aimed to massage and cleanse the scalp.

Official Title

Cleansing Device for the Treatment of Scalp and Hair Conditions

Quick Facts

Study Start:2026-05-01
Study Completion:2026-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:SUSPENDED

Study ID

NCT05319444

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants must qualify for one of the following scalp conditions based on clinical opinion of a board-certified dermatologist: healthy scalp, dandruff, seborrheic dermatitis, or hair loss disease
  2. * All Women of Child Bearing Potential must indicate use of two of the following contraceptive methods. The WaterPik device uses an ultrasonic technology which includes ultrasound. Unnecessary ultrasound is not recommended for pregnant women.
  3. * Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation (oral, intravaginal, or transdermal)
  4. * Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, or implantable)
  5. * Intrauterine device (IUD)
  6. * Intraurerine hormone-releasing system (IUS)
  7. * Vasectomized partner
  8. * Sexual abstinence
  9. * Barrier method, such as a condom
  1. * Non-English speaking
  2. * Exclusion related to pregnancy, lactation, or plans to become pregnant over the course of the study (based on self-report from the participant)
  3. * Current clinical condition that, in the opinion of the site investigator, would interfere with adherence to study requirements

Contacts and Locations

Principal Investigator

Ronda Farah, MD
PRINCIPAL_INVESTIGATOR
University of Minnesota Medical School Department of Dermatology
Maria Hordinsky, MD
PRINCIPAL_INVESTIGATOR
University of Minnesota Medical School Department of Dermatology

Study Locations (Sites)

University of Minnesota
Minneapolis, Minnesota, 55455
United States

Collaborators and Investigators

Sponsor: University of Minnesota

  • Ronda Farah, MD, PRINCIPAL_INVESTIGATOR, University of Minnesota Medical School Department of Dermatology
  • Maria Hordinsky, MD, PRINCIPAL_INVESTIGATOR, University of Minnesota Medical School Department of Dermatology

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2026-05-01
Study Completion Date2026-11

Study Record Updates

Study Start Date2026-05-01
Study Completion Date2026-11

Terms related to this study

Additional Relevant MeSH Terms

  • Dandruff
  • Seborrheic Dermatitis
  • Hair Loss